MAPS and Wesana Health Resume Negotiations
14. Dezember 2021 07:32 ET
|
Wesana Health
CHICAGO and TORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, is pleased to announce...
Wesana Completes Filing of PCT Patents for Novel Drug Protocols
09. Dezember 2021 07:30 ET
|
Wesana Health
CHICAGO and TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, is pleased to announce...
Wesana Health Reports Q3 2021 Financial Results
29. November 2021 19:05 ET
|
Wesana Health
CHICAGO and TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data driven life sciences company, has announced its...
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments
19. November 2021 07:32 ET
|
Wesana Health
CHICAGO and TORONTO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, announced today that...
Wesana Health Announces Inclusion in the AdvisorShares Psychedelics ETF
01. Oktober 2021 07:30 ET
|
Wesana Health
CHICAGO and TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on...
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline
14. September 2021 07:30 ET
|
Wesana Health
MAPS to Investigate Viability of Research Pathway for MDMA-Assisted Therapy to Treat Traumatic Brain Injury Effort Positions MAPS, Sponsor of the Only Completed Phase 3 Trial for...
Wesana Health Announces Closing of PsyTech Acquisition
09. September 2021 07:30 ET
|
Wesana Health
CHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on...
Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board
31. August 2021 07:30 ET
|
Wesana Health
TORONTO and CHICAGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), an emerging data driven life sciences company focused on...
Wesana Health: Early Warning News Release
24. August 2021 09:30 ET
|
Wesana Health
CHICAGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- “Wesana Health Holdings Inc. (“Wesana” or “The Company”)(CSE:WESA; OTCBQB: WSNAF) would like to report that Chad Bronstein (the “Reporter”) of Chicago,...
Wesana Health Highlights Recent Appointments to Board of Directors
19. August 2021 07:30 ET
|
Wesana Health
TORONTO and CHICAGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) is pleased to highlight the recent appointments of Robert...